Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN

被引:14
|
作者
Hu, Peiqi [1 ]
Su, Hua [3 ]
Xiao, Hong [1 ]
Gou, Shen-Ju [1 ]
Herrera, Carolina A. [1 ,2 ]
Alba, Marco A. [1 ]
Kakoki, Masao [1 ]
Falk, Ronald J. [1 ,2 ]
Jennette, J. Charles [1 ,2 ]
机构
[1] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Nephropathol Div, 308 Brinkhous Bullitt Bldg,CB 7525, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Med, Div Nephrol & Hypertens, Chapel Hill, NC 27599 USA
[3] Huazhong Univ Sci & Technol, Dept Nephrol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 31卷 / 02期
关键词
RELEASE; NEUTROPHILS; ACTIVATION; VASCULITIS; GLOMERULONEPHRITIS; INFLAMMATION; COMPLEMENT; EXPRESSION; MECHANISM; BLOCKADE;
D O I
10.1681/ASN.2019010032
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Myeloperoxidase-specific ANCA (MPO-ANCA) are implicated in the pathogenesis of vasculitis and GN. Kinins play a major role during acute inflammation by regulating vasodilatation and vascular permeability and by modulating adhesion and migration of leukocytes. Kinin system activation occurs in patients with ANCA vasculitis. Previous studies in animal models of GN and sclerosing kidney diseases have demonstrated protective effects of bradykinin receptor 1 (B1R) blockade via interference with myeloid cell trafficking. Methods To investigate the role of B1R in a murine model of MPO-ANCA GN, we evaluated effects of B1R genetic ablation and pharmacologic blockade. We used bone marrow chimeric mice to determine the role of B1R in bone marrow-derived cells (leukocytes) versus nonbone marrow-derived cells. We elucidated mechanisms of B1R effects using in vitro assays for MPO-ANCA-induced neutrophil activation, endothelial adherence, endothelial transmigration, and neutrophil adhesion molecule surface display. Results B1R deficiency or blockade prevented or markedly reduced ANCA-induced glomerular crescents, necrosis, and leukocyte influx in mice. B1R was not required for in vitro MPO-ANCA-induced neutrophil activation. Leukocyte B1R deficiency, but not endothelial B1R deficiency, decreased glomerular neutrophil infiltration induced by MPO-ANCA in vivo. B1R enhanced ANCA-induced neutrophil endothelial adhesion and transmigration in vitro. ANCA-activated neutrophils exhibited changes in Mac-1 and LFA-1, important regulators of neutrophil endothelial adhesion and transmigration: ANCA-activated neutrophils increased surface expression of Mac-1 and increased shedding of LFA-1, whereas B1R blockade reduced these effects. Conclusions The leukocyte B1R plays a critical role in the pathogenesis of MPO-ANCA-induced GN in a mouse model by modulating neutrophil-endothelial interaction. B1R blockade may have potential as a therapy for ANCA GN and vasculitis.
引用
收藏
页码:297 / 307
页数:11
相关论文
共 50 条
  • [1] Critical role of kinin receptor 1 (B1) in the pathogenesis of autoimmune neuroinflammation
    Aktas, Orhan
    Prat, Alexandre
    Schulze-Topphoff, Ulf
    Smorodchenko, Alina
    Mori, Marcelo
    Tran, Elise
    Prozorovski, Timour
    Radbruch, Helena
    Bader, Michael
    Zipp, Frauke
    NEUROLOGY, 2007, 68 (12) : A118 - A118
  • [2] Critical role of kinin receptor 1 (B1) in the pathogenesis of autoimmune neuroinflammation
    Schulze-Topphoff, U.
    Prat, A.
    Prozorovski, T.
    Herz, J.
    Siffrin, V.
    Schadock, I.
    Mori, M.
    Tran, E.
    Bader, M.
    Zipp, F.
    Aktas, O.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 118 - 118
  • [3] Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease
    Ohtani, Hiroshi
    Wakui, Hideki
    Komatsuda, Atsushi
    Chyzh, Konstantin A.
    Hatakeyama, Takashi
    Masai, Rie
    Okuyama, Shin
    Togashi, Masaru
    Sawada, Ken-ichi
    RENAL FAILURE, 2007, 29 (02) : 183 - 187
  • [4] Targeting kinin B1 receptor for therapeutic angiogenesis
    Emanueli, C
    Salis, MB
    Tiziana, S
    Milia, AF
    Pinna, A
    Bader, M
    Regoli, D
    Madeddu, P
    HYPERTENSION, 2001, 38 (03) : 479 - 479
  • [5] Molecular and pharmacological diversity of the kinin B1 receptor
    Hess, JF
    Hey, PJ
    Chen, TB
    Pettibone, DJ
    Chang, RSL
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (13-14) : 1747 - 1754
  • [6] Blockade of the Kinin B1 Receptor Ameloriates Glomerulonephritis
    Klein, Julie
    Gonzalez, Julien
    Decramer, Stephane
    Bandin, Flavio
    Neau, Eric
    Salant, David J.
    Heeringa, Peter
    Pesquero, Joao-Bosco
    Schanstra, Joost-Peter
    Bascands, Jean-Loup
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (07): : 1157 - 1164
  • [8] Novel Kinin B1 Receptor Splice Variant and 5′UTR Regulatory Elements Are Responsible for Cell Specific B1 Receptor Expression
    Cheah, Faang Y.
    Baltic, Svetlana
    Temple, Suzanna E. L.
    Bhoola, Kanti
    Thompson, Philip J.
    PLOS ONE, 2014, 9 (01):
  • [9] Targeting kinin B1 receptor for therapeutic neovascularization
    Emanueli, C
    Salis, MB
    Stacca, T
    Pintus, G
    Kirchmair, R
    Isner, JM
    Pinna, A
    Gaspa, L
    Regoli, D
    Cayla, C
    Pesquero, JB
    Bader, M
    Madeddu, P
    CIRCULATION, 2002, 105 (03) : 360 - 366
  • [10] KININ B1 RECEPTOR INHIBITION IN AIRWAY INFLAMMATION
    Gurusamy, M.
    Nasseri, S.
    Wu, D.
    RESPIROLOGY, 2014, 19 : 14 - 14